Blood holds clues to liver cancer treatment success

NCT ID NCT07303712

Summary

This study is testing whether simple blood tests can predict how well a radiation treatment (Y90) works for liver cancer. Researchers will collect blood samples from 12 patients before and after treatment to look for cancer signals. The goal is to see if these blood signals can tell doctors early on whether the treatment is working, potentially helping guide future care.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • VA Palo Alto Health Care System

    RECRUITING

    Palo Alto, California, 94304, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.